COVID-19, Product Selection, and The Performance of Pharmaceutical Enterprises: Evidence from China
DOI:
https://doi.org/10.54691/bcpbm.v49i.5440Keywords:
COVID-19; Pharmaceutical Industry; Firm Performance; Product Selection; Business domain; CSR.Abstract
Since the worldwide outbreak of COVID-19, enterprises all the world have suffered from a crisis, which both threats human health and impacts production activities. Due to the particularity of listed companies in the pharmaceutical industry up against COVID-19, this study evaluates how COVID-19 affects the financial performance of pharmaceutical companies and the influential factors of the performance differentiation. Our research shows that COVID-19 leads to a decline in the performance of listed companies in the pharmaceutical industry. However, the impacts vary because of different domains of main products, among which the impact on listed companies producing commodities related to epidemic prevention and control such as vaccines and masks shows the least significant. In addition to the factors of listed companies themselves, we also find that companies located in less economically advantaged and less densely populated areas are slightly less impacted. According to the research results, policymakers should consider strengthening the financial supervision of enterprises and paying attention to the implementation of public health work. Moreover, business managers should choose suitable domains of main products and key development areas to reduce the negative impact of potential economic recession.
Downloads
References
WHO. Title of subordinate document. In: Coronavirus disease (COVID-19) outbreak situation. WHO. 2022. Https://www.who.int/emergencies/diseases/novel-coronavirus-2019. Accessed 27 June 2022.
Chudik A, Mohaddes K, Pesaran MH, Raissi M, Rebucci A. A Counterfactual Economic Analysis of COVID-19 Using a Threshold Augmented Multi-Country Model. Globalization Institute Working Papers. 2020. DOI: https://doi.org/10.3386/w27855
WHO. Title of subordinate document. In: Coronavirus disease (COVID-19)/COVID-19 vaccines. WHO. 2022. Https://www.who.int/emergencies/diseases/novel-coronavirus-2019/covid-19-vaccines. Accessed 27 June 2022.
Ayati N, Saiyarsarai P, Nikfar S. Short and long term impacts of COVID-19 on the pharmaceutical sector.Daru. Dec 2020; 28 (2): 799-805. DOI: https://doi.org/10.1007/s40199-020-00358-5
Title of subordinate document. In: GDP. National Bureau of Statistics. 2022 https://data.stats.gov.cn/easyquery.htm? CN=B01. Accessed 27 June 2022.
Wahlen J M , Baginski S P , Bradshaw M . Financial Reporting, Financial Statement Analysis and Valuation: A Strategic Perspective[J]. Spine, 2011.
Singhal R, Fu L, Parkash M. Tobin's q Ratio and Firm Performance. International Research Journal of Applied Finance. 2016; VII (4).
Zouaoui M, Nouyrigat G, Beer F. How does investor sentiment effect stock market crises? Evidence from panel data. Financial Review. 2011; 46 (4): 723-747. DOI: https://doi.org/10.1111/j.1540-6288.2011.00318.x
Aifuwa H O , Saidu M , Aifuwa S A . Coronavirus Pandemic Outbreak and Firms Performance in Nigeria[J]. Human Resource Management Review, 2020, 9(4):15-25.
Donadelli M, Kizys R, Riedel M. Dangerous infective diseases: Bad news for Main Street, good news for Wall Street? Journal of Financial Markets. 2017; 35. DOI: https://doi.org/10.1016/j.finmar.2016.12.003
West NEJ, Cheong WF, Boone E, Moat NE. Impact of the COVID-19 pandemic: a perspective from industry. Eur Heart J Suppl. Dec 2020; 22 (Suppl Pt t): P56-P59. DOI: https://doi.org/10.1093/eurheartj/suaa187
Ural D. Title of subordinate document. In: Evaluating Pharma Amid COVID-19. https://www.contactpharma.com/contents/view_online-exclusives/2020-05-18/evaluating-pharma-amid-covid-19/. Accessed 18 May 2020.
Sun Y, Bao Q, Lu Z. Coronavirus (Covid-19) outbreak, investor sentiment, and medical portfolio: Evidence from China, Hong Kong, Korea, Japan, and U.S. Pacific-Basin Finance Journal. 2021; 65 (4): 101,463. DOI: https://doi.org/10.1016/j.pacfin.2020.101463
Wang Z, Zhang Z, Zhang Q, Gao J, Lin W. COVID-19 and financial market response in China: Micro evidence and possible mechanisms.PLoS One. 2021; 16 (9): e0256879. DOI: https://doi.org/10.1371/journal.pone.0256879
Zheng F, Zhao Z, Sun Y, Khan YA. Financial performance of China's listed firms in presence of coronvirus: Evidence from corporate culture and corporate social responsibility.Curr Psychol.Aug 11 201: 1-22.
Ali M, Alam N, Rizvi S. Coronavirus (COVID-19)-An Epidemic or Pandemic for Financial Markets. Journal of Behavioral and Experimental Finance. 2020 27: 100341.. DOI: https://doi.org/10.1016/j.jbef.2020.100341
Da A, Sb B, Jmb C, et al. Economic Before and During the COVID-19 pandemic.Journal of Public Economic.2020; 191.
Anita, M., McGahan, Michael, E., Porter. Comment on 'Industry, corporate and business-segment effects and business performance: a non-parallel approach' by Ruefli and Wiggins. Strategic Management Journal. 2005. DOI: https://doi.org/10.1002/smj.480
Short JC, Ketchen DJ, Palmer TB, Hult G. Firm, strategic group, and industry influences on performance. Strategic Management Journal. 2007; 28 (2). DOI: https://doi.org/10.1002/smj.574
Houthoofd N, Desmidt S, Fidalgo EG. Analysis firm performance heterogeneity: The Relative Effect of Business Domain.Management Decision.2010; 48 (6): 996-1009. DOI: https://doi.org/10.1108/00251741011053505
Sidhu JS. Business-domain definition and performance: an empirical study. Sam Advanced Management Journal. 2004; 69 (4): 40-45.
Schnepp R. S. M. Social Responsibilities of the Businessmanby Howard R. Bowen. American Catholic Social Review. 1954; 15 (1): 42-43. DOI: https://doi.org/10.2307/3708003
Davis K. Understanding the social responsibility puzzle. Business Horizons. 1967; 10 (4): 45-50. DOI: https://doi.org/10.1016/0007-6813(67)90007-9
Michael, Schrder. Financial effects of corporate social responsibility: a literature review. Journal of Sustainable Finance & Investment.2014; 4 (4): 337-350. DOI: https://doi.org/10.1080/20430795.2014.971096
Bird R, Hall AD, Moment è F, Reggiani F. What Corporate Social Responsibility Activities are Valued by the Market? Journal of Business Ethics. 2007; 76 (2): 189-206. DOI: https://doi.org/10.1007/s10551-006-9268-1
Minor D, Morgan J. CSR as Reputation Insurance: Primum Non Nocere. California management review. 2011; 53 (3): p.40-59. DOI: https://doi.org/10.1525/cmr.2011.53.3.40
Edmans A. The Link Between Employee Satisfaction and Firm Value, With Implications for Corporate Social Responsibility. 2012. DOI: https://doi.org/10.2139/ssrn.2054066
Chu DK, Akl EA, Stephanie D, et al. Physical distancing, face masks, and eye protection to advance person-to-person transmission of SARS-CoV-2 and COVID-19: a systematic review and meta-analysis. Lancet (London, England). 395 (10242): 1973-1987.
Kucharski AJ, Klepac P, Conlan A, Kissler SM, Simons D. Effectiveness of isolation, testing, contact tracing, and physical distancing on reducing transmission of SARS-CoV-2 in different settings: a mathematical modelling study. The Lancet Infective Diseases.2020. DOI: https://doi.org/10.1101/2020.04.23.20077024
Hassan T A , Hollander S , Lent L V , et al. Firm-level Exposure to Epidemic Diseases: Covid-19, SARS, and H1N1[J]. Working Papers Series, 2020. DOI: https://doi.org/10.3386/w26971
Nicola M, Alsafi Z, Sohrabi C, Kerwan A, Agha R. The Social-Economic Implications of the Coronavirus and COVID-19 Pandemic: A Review. International Journal of Surgery (London, England). 2020; 78. DOI: https://doi.org/10.1016/j.ijsu.2020.04.018
China NHCotPsro. Title of subordinate document. In: Notice on further strengthening the quality control of Novel Coronavirus Nucleic acid Samples. 2022.
http://www.nhc.gov.cn/yzygj/s7659/202206/abf52e7f45b147a993a36a2259011f48. shtml. Accessed 20 July 2022.
Rodr í guez-Urrego D, Rodr í guez-Urrego L. Air quality during the COVID-19: PM2.5 analysis in the 50 most published capital cities in the world. Environmental Pollution. 2020; 266 (Pt 1): 115042. DOI: https://doi.org/10.1016/j.envpol.2020.115042
Gu J, Shi Y, Zhu Y, et al. Ambient air collection and cause-specific risk of hospital admission in China: A nationwide time-series study. PLoS Med. Aug 2020; 17 (8): e1003188. DOI: https://doi.org/10.1371/journal.pmed.1003188
Lim ZJ, Ponnapa Reddy M, Afroz A, Billah B, Shekar K, Subramaniam A. Incidence and outcome of out-of-hospital cardiac arrests in the COVID-19 era: A systematic review and meta-analysis. Resuscitation.Dec 2020; 157: 248-258. DOI: https://doi.org/10.1016/j.resuscitation.2020.10.025
Pe ç anha T, Goessler KF, Roschel H, Gualano B. Social isolation during the COVID-19 pandemic can increase physical inactivity and the global burden of cardiovascular disease. Am J Physiol Heart Circ Physiol. Jun 1 2020; 318 (6): H1441-h1446. DOI: https://doi.org/10.1152/ajpheart.00268.2020
Gan Y, Ma J, Wu J, Chen Y, Zhu H, Hall BJ. Immediate and delayed psychological effects of province-wide lockdown and personal quarantine during the COVID-19 outbreak in China. Psychological Med. May 2022; 52 (7): 1321-1332. DOI: https://doi.org/10.1017/S0033291720003116
Leichenko R. Climate change and urban resilience. Current Opinion in Environmental Sustainability. 2011; 3 (3): 164-168. DOI: https://doi.org/10.1016/j.cosust.2010.12.014
Zhang M, Chen W, Cai K, et al. Analysis of the Spatial Distribution Characters of Urban Resilience and It Influencing Factors: A Case Study of 56 Cities in China. International Journal of Environmental Research and Public Health. 2019; 16 (22): 4442. DOI: https://doi.org/10.3390/ijerph16224442
Sy KTL, White LF, Nichols BE. Population density and basic reproduced number of COVID-19 across United States counties. PLoS One. 2021; 16 (4): e0249271. DOI: https://doi.org/10.1371/journal.pone.0249271
Szczygielski JJ, Charteris A, Bwanya PR, Brzeszczy å ski J. The impact and role of COVID-19 industry: A global industry analysis. International Review of Financial Analysis. 2021 (35): 101,837. DOI: https://doi.org/10.1016/j.irfa.2021.101837
Hu S, Zhang Y. COVID-19 pandemic and firm performance: Cross-country evenness. International Review of Economics & Finance. 2021; 74 (1). DOI: https://doi.org/10.1016/j.iref.2021.03.016
Bai M, Ho L. Corporate social performance and firm debt levels: Impacts of the covid-19 pandemic and institutional environments. Finance Research Letters. 2022; 47. DOI: https://doi.org/10.1016/j.frl.2022.102968
Tang Z, Hull CE, Rothenberg S. How Corporate Social Responsibility Engineering Strategy Moderates the CSR-Financial Performance Relationship. Journal of Management Studies. 2012; 49 (7). DOI: https://doi.org/10.1111/j.1467-6486.2012.01068.x
Krenz A, Strulik H. The benefits of remoteness-digital mobility data, regional road infrastructure, and COVID-19 infections. G ö ttingen: University of G ö ttingen, Center for Europe, Government and Economic Development Research (cege). 2021 (3). DOI: https://doi.org/10.1515/ger-2020-0068
Downloads
Published
Issue
Section
